Adept patent prosecution for biotech and pharmacology clients
Jason Glanzer is a patent prosecution attorney with a focus in biotechnology and pharmacology. He has over 20 years of experience in academic research, having worked on a wide variety of genomic, proteomic, drug discovery and gene editing platforms.
Jason has authored over 20 peer-reviewed articles related to cancer biology and immunology, and has received a patent for developing a method for single-cells analysis. His development of a drug discovery platform for novel anti-cancer compounds garnered a university-wide award for most promising new invention. Raised on a diversified family farm in Nebraska, Jason is knowledgeable of the methods of crop and animal production and has keen insights into the development of GMOs in the agriculture sector.
Admitted in Nebraska. Not admitted in Wisconsin.
Professional & Civic Activities
- American Intellectual Property Law Association, member
- Nebraska State Bar Association – Executive Committee member, Intellectual Property Section
- Creighton University School of Law (J.D., 2018)
- University of Nebraska Medical Center (Ph.D., 2002)
- Ph.D. Pharmacology
- University of Nebraska at Omaha (B.S., 1994)
- Major: Biotechnology
- U.S. District Court, District of Nebraska
- Supreme Court of Nebraska
- U.S. Patent and Trademark Office